Mahady G B
Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA.
J Nutr. 2001 Mar;131(3s):1120S-3S. doi: 10.1093/jn/131.3.1120S.
Over the past decade, herbal medicine has become a topic of increasing global importance, with both medical and economic implications. In developing countries, as much as 80% of the indigenous populations depends on traditional systems of medicine and medicinal plants as their primary source of healthcare. Within the European Community, herbal medicines represent an important share of the pharmaceutical market, with annual sales in the range of US$7 billion. In the United States, the sale of herbal products has skyrocketed from $200 million in 1988 to >$3.3 billion in 1997. Such widespread use of botanicals throughout the world has raised serious questions concerning the quality, safety and efficacy of these products. Thus, accurate scientific assessment of herbal medicine is a prerequisite for global harmonization of herbal health claims. In 1995, as part of its overall global strategy of "Health for All" and due to numerous requests from the member states, the Traditional Medicine Program of the WHO began the extensive task of reviewing the world's scientific literature of commonly used herbal medicines and publishing this information in monographs. The WHO monographs are technical reviews of the quality, safety and efficacy of commonly used herbal medicines and are intended primarily to harmonize the proper use of herbal medicines throughout the world.
在过去十年中,草药已成为一个在全球范围内重要性日益增加的话题,具有医学和经济两方面的影响。在发展中国家,多达80%的本土人口依赖传统医学体系和药用植物作为其主要的医疗保健来源。在欧洲共同体内部,草药在药品市场中占据重要份额,年销售额达70亿美元左右。在美国,草药产品的销售额已从1988年的2亿美元飙升至1997年的超过33亿美元。植物药在全球范围内如此广泛的使用引发了有关这些产品质量、安全性和有效性的严重问题。因此,对草药进行准确的科学评估是全球统一草药健康声称的先决条件。1995年,作为其“人人享有健康”总体全球战略的一部分,并应成员国的众多要求,世界卫生组织传统医学项目开始了一项广泛的任务,即审查世界上关于常用草药的科学文献,并将这些信息发表在专论中。世界卫生组织的专论是对常用草药的质量、安全性和有效性的技术审查,主要目的是在全球范围内统一草药的合理使用。